Physician profile
Derek T Murphy
NPI 1619014628
$10,418.47
in general payments reported to CMS, 2019-2025
59 companies · $915 in 2025
The $915 reported for 2025 was more than what 83% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $299 · 2020: $1,303 · 2021: $2,125 · 2022: $2,930 · 2023: $1,863 · 2024: $985 · 2025: $915.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,750 · Education: $12.01.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,749.98 |
| Education | $12.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,135.34 | 2021-2025 | |
| Vanda Pharmaceuticals INC. | $1,289.17 | 2022-2025 | Fanapt, Hetlioz |
| Lilly USA, LLC | $670.43 | 2020-2024 | Emgality, Mounjaro, Reyvow |
| Esperion Therapeutics, INC. | $628.26 | 2021-2025 | Nexletol |
| Novo Nordisk INC | $418.88 | 2019-2024 | Wegovy, Rybelsus, Ozempic |
| Antares Pharma, INC. | $397.91 | 2021-2025 | Xyosted, Tlando, Nocdurna |
| Boehringer Ingelheim Pharmaceuticals, INC. | $391.47 | 2019-2023 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $288.65 | 2021-2023 | |
| Arbor Pharmaceuticals, INC. | $271.98 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $271.44 | 2019-2023 | Belsomra, Verquvo, Steglatro |
| Novartis Pharmaceuticals Corporation | $263.88 | 2020-2023 | |
| Kowa Pharmaceuticals America, INC. | $260.40 | 2020-2023 | Livalo, Seglentis |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $185.24 | 2022-2023 | |
| Allergan, INC. | $182.29 | 2020 | |
| Adlon Therapeutics L.P. | $179.53 | 2020-2021 |
Show all 59 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Derek Murphy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.